Chromosome 5q33 deletions associated with congenital heart defects
Molly Starkovich1, Seema R Lalani1, Catherine L Mercer2
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
Insights
Congenital heart defects (CHD) can be linked to specific gene deletions on chromosome 5q33. Haploinsufficiency of HAND1 and SAP30L genes may contribute to CHD development, though other factors influence outcomes.
Area of Science:
- Genetics
- Developmental Biology
- Human Physiology
Background:
- Congenital heart defects (CHD) affect over 1% of newborns, representing a leading cause of birth defect mortality in the U.S.
- Understanding the genetic underpinnings of CHD is crucial for diagnosis and treatment.
Observation:
- Two male subjects with complex CHD presented with partially overlapping, de novo deletions on chromosome 5q33.
- The overlapping deletion region included HAND1 and SAP30L, genes implicated in cardiac development.
- Two additional individuals with deletions involving HAND1 and SAP30L showed no cardiac issues.
Findings:
- Haploinsufficiency of HAND1, a transcription factor, causes cardiac defects in mouse models.
- SAP30L plays a role in transcriptional regulation and its knockdown in zebrafish leads to cardiac problems.
- The study suggests HAND1 and/or SAP30L haploinsufficiency may contribute to CHD development.
Implications:
- The findings suggest that HAND1 and SAP30L are candidate genes for CHD, but other genes in the deleted region may also play a role.
- The incomplete penetrance of CHD in individuals with 5q33 deletions highlights the influence of genetic, environmental, and stochastic factors.
- Further research is needed to fully elucidate the genetic architecture of CHD and the role of 5q33 deletions.
Abstract:
Congenital heart defects (CHD) are present in over 1% of all newborns and are the leading cause of birth-defect-related deaths in the United States. We describe two male subjects with CHD, one with an atrial septal defect, a ventricular septal defect, and pulmonary artery stenosis; and the other with tetralogy of Fallot and a right aortic arch, who carry partially overlapping, de novo deletions of chromosome 5q33. The maximum region of overlap between these deletions encompasses HAND1 and SAP30L, two genes that have previously been shown to play a role in cardiac development. HAND1 encodes a basic helix-loop-helix transcription factor. Cardiac-specific ablation of Hand1 in mice causes septal, valvular, and outflow tract defects. SAP30L, its paralog SAP30, and other SAP proteins form part of a multi-subunit complex involved in transcriptional regulation via histone deacetylation. Morpholino knockdown of sap30L in zebrafish, which do not have a distinct sap30 gene, leads to cardiac hypoplasia and cardiac insufficiency. We subsequently identified two other individuals with chromosomal deletions involving HAND1 and SAP30L in whom cardiac-related medical problems were not described. These observations suggest that haploinsufficiency of HAND1 and/or SAP30L may contribute to the development of CHD, although the contribution of other genes on chromosome 5q33 cannot be excluded. Our findings also suggest that the penetrance of CHD associated with 5q33 deletions is incomplete and may be influenced by other genetic, environmental or stochastic factors. © 2016 Wiley Periodicals, Inc.
Related Concept Videos
Karyotyping
Karyotyping
Chromosome Duplication
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Nondisjunction
Nondisjunction


